We are live on ! Find out more
AZN icon

AstraZeneca

981 hedge funds and large institutions have $34.2B invested in AstraZeneca in 2022 Q1 according to their latest regulatory filings, with 120 funds opening new positions, 340 increasing their positions, 299 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more first-time investments, than exits

New positions opened: 120 | Existing positions closed: 79

31% more funds holding in top 10

Funds holding in top 10: 1317 (+4)

17% more capital invested

Capital invested by funds: $29.4B → $34.2B (+$4.85B)

14% more repeat investments, than reductions

Existing positions increased: 340 | Existing positions reduced: 299

3% more funds holding

Funds holding: 949981 (+32)

10% more call options, than puts

Call options by funds: $495M | Put options by funds: $450M

0.4% more ownership

Funds ownership: 16.27%16.67% (+0.4%)

Holders
981
Holders Change
+32
Holders Change %
+3.37%
% of All Funds
15.47%
Holding in Top 10
17
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+30.77%
% of All Funds
0.27%
New
120
Increased
340
Reduced
299
Closed
79
Calls
$495M
Puts
$450M
Net Calls
+$44.6M
Net Calls Change
-$159M
Name Holding Trade Value Shares
Change
Change in
Stake
TCOT
526
Trust Company of Toledo
Ohio
$511K +$72K +600 +18%
1WA
527
180 Wealth Advisors
Washington
$508K -$30.9K -258 -6%
NP
528
NorthRock Partners
Minnesota
$507K +$35K +292 +8%
GWM
529
GDS Wealth Management
Texas
$506K -$93.7K -781 -17%
HJIM
530
Henry James International Management
New York
$502K
CAM
531
Cozad Asset Management
Illinois
$499K
BP
532
Ballentine Partners
Massachusetts
$499K +$1.32K +11 +0.3%
VF
533
Virtu Financial
New York
$499K +$452K +3,765 New
PCA
534
Personal Capital Advisors
California
$498K -$79.5K -663 -15%
CIAS
535
Capital Investment Advisory Services
North Carolina
$489K -$62.8K -524 -12%
MW
536
Marcum Wealth
Ohio
$486K +$81.3K +678 +23%
LCM
537
LVM Capital Management
Michigan
$484K
SL
538
Stevard LLC
Illinois
$481K
IAA
539
Independent Advisor Alliance
North Carolina
$481K +$33.3K +278 +8%
LAS
540
LWM Advisory Services
Florida
$478K -$5.64K -47 -1%
BIAS
541
Beacon Investment Advisory Services
New Jersey
$474K -$6.6K -55 -2%
FIM
542
Fruth Investment Management
Texas
$474K
MCM
543
MAI Capital Management
Ohio
$466K +$74.1K +618 +21%
JCM
544
Jacobi Capital Management
Pennsylvania
$463K -$24.3K -203 -5%
MNBTD
545
Moody National Bank Trust Division
Texas
$463K
GAMC
546
Garner Asset Management Corp
Texas
$458K
HW
547
Hancock Whitney
Mississippi
$457K -$29.3K -244 -7%
Verition Fund Management
548
Verition Fund Management
Connecticut
$456K -$7.68M -64,060 -95%
WAP
549
Wealthcare Advisory Partners
Pennsylvania
$452K -$26.3K -219 -6%
AG
550
Ascent Group
Virginia
$448K +$62.7K +523 +18%

AZN Hedge Fund Activity: Q1 2022 in Review

981 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q1 2022, worth a combined $34.2B — up 17% from $29.4B a quarter earlier.

Buyers outnumbered sellers: 120 funds opened new AZN positions and 79 closed out — a net gain of 41 holders — while 340 added to existing stakes and 299 trimmed.

The largest buyer was Franklin Resources, adding an estimated $317M. The largest seller was HSBC Holdings, cutting an estimated $414M.

  • 981 institutional investors held AstraZeneca (AZN) as of Q1 2022, up from 949 in Q4 2021.
  • Funds reported $34.2B of AstraZeneca stock for Q1 2022, up 17% quarter-over-quarter.
  • 120 funds opened new AstraZeneca positions in Q1 2022 and 79 closed out, a net change of +41 holders.
  • The largest AstraZeneca buyer in Q1 2022 was Franklin Resources, an estimated $317M added.
  • The largest AstraZeneca seller in Q1 2022 was HSBC Holdings, an estimated $414M sold.

Based on aggregated 13F filings for Q1 2022.